Business Summary Management Board of Directors Joint Auditors Company Registrar Subsidiaries/Associates Capital Structure

   FIDSON

Select Quote:
Index: 37024.72 -60.40 -0.16%
Business Summary Management Board of Directors Company Secretary Company Registrars Subsidiaries/Associates Joint Auditors Quote Login
Sector:
Healthcare
Sub-Sector:
Pharmaceuticals
Listing Date:
4th June, 2008.
End of Accounting Year:
30 Jun
Share Outstanding:
1,500,000,000.00
NSE code
FIDSON
AGM Date:
23-02-2011


You need to upgrade your Flash Player
You need to upgrade your Flash Player
You need to upgrade your Flash Player
You need to upgrade your Flash Player

No. Of Deals:   60.00


Volume Traded:   3,746,898.00


Value Traded:    8,138,435.66


52 Weeks High:  2.50


52 Weeks Low:    0.70

Open Price:    2.01


Close Price:    2.21


High Price:    2.21


Low Price:    2.01


Year To Date Appreciation:   -38.61 

 


1 Week Change (%)


1 Month Change (%)


6 Months Change (%)


1 Year Change (%)

FIDSON


-11.6


41.67


114.56


142.86

NSE All-share Index


-7.47


0.32


34.94


76.07

Quarterly Results For FIDSON

20th May, 2013: 1st Quarter Results for the Period Ending 31-Mar-2013


Values
2013 N'm
2012 N'm
% Change
Profit & Loss Information
Turnover
2,624
1,696
54.72%
Cost of Sales
-1,154
-741
55.7%
Profit Before Tax
270
173
55.44%
Taxation
-75
-52
44.28%
Profit Or Loss After Tax
195
121
60.23%
Balance Sheet Information
Fixed Assets
4,784
4,679
2.24%
Cash & Bank Balances
143
243
-41.16%
Working Capital
2,772
2,197
26.17%
Net Assets
5,497
5,228
5.15%
  VALUATION MEASURES
Market Cap :
3,315,000,000.00
EPS:
0.13
P/E:
17.04
Book Value :
N/A
Book Value Per Share :
N/A
Price/Book
N/A
  FINANCIAL HIGHLIGHTS
  Fiscal
Fiscal Year End
30 Jun
Most Recent Quarter
1st Quarter
  Profitability
Profit Before Tax Margin
10.27
Profit After Tax Margin
7.41
Profit Before Tax Growth
55.44
Profit After Tax Growth
60.23
  Management Effectiveness
Return On Assets
0.04
Return On Equity
0.04


  INCOME STATEMENT
Revenue:
N2,624.00(mln)
Revenue Per Share :
1.75
Revenue Growth :
54.72%
   Balance Sheet
Total Cash
143.23
Shareholder Fund Growth
5.15%
Loan Growth
0.00%
Deposit Growth
0.00%
Fixed Asset Growth
2.24%
  Dividends & Splits
Dividend:
0.12 (0000-00-00)
Bonus Declared
  TRADING INFORMATION
  Stock Price History
52-week Change:
142.86%
52-week Change
(relative to NSE Index)
76.07%
52-Week High:
2.50
52 Week Low :
0.70
50-Day Moving Average :
1.75
200-Day Moving Average:
1.38
  Share Statistics
Ave. Volume (3 month):
2,926,795.35
Ave. Volume (10 days):
8,056,063.90
Shares Outstanding:
1,500,000,000.00
Daily Volume
3,746,898.00


Fidson Healthcare Plc
Balance Sheet as at 30 June 2010
Assets employed
2010
2009
Fixed Assets
2,150,631
1,903,839
Finance Lease Assets
73,423
110,648
Investments
2,813,932
2,584,086
5037986
4598573
Current Assets
Stocks
714,317
666,214
Debtors and Prepayments
1,850,131
1,687,122
Due from Related Companies
67,065
150,556
Cash at bank and in hand
232,831
79,223
2,864,344
2,583,115
Creditors due within one year
-2,083,228
-1,544,080
Taxation
-468,285
-370,284
Net Current Assets
312831
668751
Total Assets Less Current Liabilities
5,350,817
5,267,324
Obligation under finance lease
-15,038
-33,866
Deferred taxation
-100,325
-134,012
Staff retirement benefits
-4,540
-4,425
5230914
5095021
Capital and Reserves
Share capital
750,000
750,000
Share Premium
2,973,043
2,973,043
Fixed Assets revaluation reserve
26,279
26,279
Revenue Reserve
1,481,592
1,345,699
5230914
5095021
PROFIT AND LOSS ACCOUNTS
For the year ended 30 June 2010
Turnover
5100523
5019778
Cost of sales
1,071,460,281
1,071,467,475
Gross Profit
2,818,980
2,745,429
Administrative Expenses
1,071,733,969
1,071,704,951
Financial Charges
-207,646
-191,208
Other operating income
38,704
105,688
Profit before taxation
642,183
623,036
Taxation
-176,290
-193,963
Profit after taxation
465893
429073
Earnings per share (kobo)
31k
29k
Dividend per share (kobo) (proposed)
10k
22k
Statement of Cash Flows
For the period ended 30 June 2010
Cashflows from operating activities
Cash received from customers
4,976,218
6,266,014
Cash Paid to suppliers and employees
1,070,043,382
1,069,410,626
Tax Paid
-111,976
-76,720
Net cash provided by operating activities
1165800
1858096
Cashflows from investing activities
Purchase of fixed assets
-343,486
1,072,552,719
Additions to finance lease assets
-19,900
-28,550
Investment in related companies
-505,943
1,073,096,619
Investment in other companies
276,098
157,866
Proceeds from sale of fixed assets
15,305
9,376
Net cash utilized by investing activities
-577926
-1695618
Cash flows from financing activities
Lease repayment
-18,828
-12,379
Interest paid on loans and overdraft
-207,646
-191,208
Dividend paid
-330,000
-382,074
Net cash utilized by financing activities
-556474
-531661
Net increase/(decrease) in cash and cash equivalents
31,400
-369,183
Cash and cash equivalents at July 1,
-248,363
120,820
Cash and cash equivalents at June 30,
-216963
-248363
Investment Valuation Ratios
Dividend Per Share
-0
Profitability Ratios
Operating Profit Margin(%)
0
Gross Profit Margin(%)
0.55%
Return On Capital Employed(%)
0.12%
Return On Net Worth(%)
0.09%
Return on Assets
0.09%
Liquidity And Solvency Ratios
Cash Flow Indicator Ratios
Earning Retention Ratio
1.71%
Earnings Per Share
0
Fixed Assets Turnover Ratio
2
OPERATING PROFIT MARGIN
INTEREST COVERAGE
-3
PBT Margin (%)
0.13%
PAT Margin (%)
0.09%
PBT Growth
0.03%
PAT growth
0.09%
SHF Growth
0.03%
Assets Growth
0.10%
Announcement Date
Agm Date
Book Closure
Address
--
2010-02-25
2010-01-19
27th Jan, 2011
2011-02-23
2011-02-03
Sheraton Hotel and Towers Ikeja, Lagos State
Bonus
Bonus Type
Announcement Date
Payment Date
Closure Date
Dividend
Dividend Type
Announcement Date
Payment Date
Closure Date
0.12
FINAL
2nd May, 2013
--
0000-00-00
0.10
FINAL
20th April, 2012
--
0000-00-00
0.10
FINAL
27th Jan, 2011
2011-03-11
2011-02-03
0.22
FINAL
--
--
2010-01-19
0.2
--
--
--
2008-12-19
Right Ratio
Face Value
Announcement Date
Record Date
Ex-right Date
Premium
Old Face Value
New Face Value
Announcement Date
Ex-split Date
Meeting Date
Remark/Outcome